Galenica Personalvorsorgestiftung

Galenica Personalvorsorgestiftung

Galenica Personalvorsorgestiftung was established in 1940 as the occupational pension vehicle for employees of Galenica AG, the Bern-headquartered pharmaceutical and healthcare logistics group. For over eight decades, the foundation operated as the primary retirement savings scheme for the Galenica workforce, accumulating and stewarding long-dated capital under the oversight of a board of trustees chaired by Alexandros Sigalas. The fund's formation paralleled the growth of Galenica's domestic pharmaceutical distribution network, embedding the pension vehicle within the broader Swiss dual-pillar retirement architecture. The foundation deploys capital across private equity, real estate, and infrastructure, a classic tripartite allocation pattern for Swiss pension funds seeking to match long-term liabilities with illiquidity premia. The real estate portfolio includes the Galenica headquarters building at Untermattweg 8 in Bern, a commercial property directly tied to the sponsoring employer's operations. The infrastructure portfolio holds global exposures, a common feature of Swiss Pensionskassen that access international infrastructure funds to diversify beyond the domestic real estate market. The foundation is a member of ASIP, the Swiss Association of Pension Institutions, which sets governance standards for occupational pension funds across the country. The corporate restructuring of Galenica AG in 2017 split the company into two listed entities — Galenica AG (the pharmacy and logistics business) and Vifor Pharma AG (the specialty pharmaceuticals division). The pension fund's sponsoring employer shifted to Vifor Pharma as part of this separation. In June 2020, the foundation formally changed its name to Vifor Pharma Pensionskasse, aligning its identity with the new corporate sponsor. That sponsorship changed again in 2022 when Australia's CSL Limited acquired Vifor Pharma for approximately $12 billion, making the pension fund part of a global biopharmaceutical group's Swiss occupational benefits structure. The fund's structure reflects the Swiss legal framework for autonomous pension foundations, where a board of trustees with equal employer-employee representation governs the vehicle independently of the sponsoring corporation's balance sheet. This governance separation — standard under Swiss BVG law but structurally distinct from Anglo-American corporate pension models — means the foundation's assets are ring-fenced from CSL's commercial operations, with investment decisions made solely in the interest of beneficiaries.